Alexandra J. Berges
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alexandra J. Berges has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Rafael Ospino
Johns Hopkins University School of Medicine, 601 N Caroline St, Suite 6214, Baltimore, MD, USA
6 shared publications - Alexander T. Hillel
Department of Otolaryngology‐Head and Neck Surgery Johns Hopkins School of Medicine Baltimore Maryland USA
5 shared publications - Ioan Lina
Department of Otolaryngology Head and Neck Surgery Johns Hopkins University School of Medicine Baltimore Maryland U.S.A.
5 shared publications - Kevin M. Motz
Department of Otolaryngology – Head and Neck Surgery Johns Hopkins University School of Medicine Baltimore Maryland USA
4 shared publications Samuel Collins
Johns Hopkins Department of Otolaryngology–Head and Neck Surgery Baltimore Maryland U.S.A.
4 shared publications- Alexander Gelbard
Vanderbilt University Medical Center, Nashville
2 shared publications
Latest Publications
- Open Access
- 11 March 2026
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
Treatment Paradigms in the Management of Skull Base Osteoradionecrosis of the Frontal Bone: The Role of Reconstruction
To characterize contemporary management strategies and reconstructive techniques for frontal bone osteoradionecrosis (ORN) following anterior skull base surgery and radiation therapy (RT). Retrospective case series. Tertiary academic medical center. Patients who underwent craniotomies for anterior skull base tumors between 2008 and 2023 and received postoperative RT. Incidence, timing, and management of frontal bone ORN, including reconstructive approaches and surgical outcomes. Among 39 patients meeting inclusion criteria, 7 (18%) developed frontal bone ORN after anterior skull base surgery and radiation. All affected patients received adjuvant radiation with a mean cumulative dose of 67.2 Gy (range, 62.4–69.6). ORN was diagnosed at a mean of 28.7 months (range, 2–78) following completion of radiation therapy. Five patients (71%) underwent surgical intervention, which universally included debridement and hardware removal. Reconstructive strategies comprised temporalis muscle flap (20%), titanium cranioplasty (60%), free flap reconstruction (60%), and custom-designed cranial implants (60%). Primary free flaps included radial forearm (n = 2) and latissimus dorsi (n = 1), with two patients later requiring anterolateral thigh flaps. Median follow-up was 10 years (range, 6.7–14.3), during which patients underwent a median of 2.5 reconstructive procedures (range, 0–6). Management of frontal bone ORN often requires complex revision cranioplasty and free flap reconstruction. Most patients required multiple surgeries to achieve stable wound healing, underscoring the importance of early recognition and consideration of prophylactic strategies in high-risk, irradiated patients. 4.
- 11 March 2026
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
Open AccessTreatment Paradigms in the Management of Skull Base Osteoradionecrosis of the Frontal Bone: The Role of Reconstruction
To characterize contemporary management strategies and reconstructive techniques for frontal bone osteoradionecrosis (ORN) following anterior skull base surgery and radiation therapy (RT). Retrospective case series. Tertiary academic medical center. Patients who underwent craniotomies for anterior skull base tumors between 2008 and 2023 and received postoperative RT. Incidence, timing, and management of frontal bone ORN, including reconstructive approaches and surgical outcomes. Among 39 patients meeting inclusion criteria, 7 (18%) developed frontal bone ORN after anterior skull base surgery and radiation. All affected patients received adjuvant radiation with a mean cumulative dose of 67.2 Gy (range, 62.4–69.6). ORN was diagnosed at a mean of 28.7 months (range, 2–78) following completion of radiation therapy. Five patients (71%) underwent surgical intervention, which universally included debridement and hardware removal. Reconstructive strategies comprised temporalis muscle flap (20%), titanium cranioplasty (60%), free flap reconstruction (60%), and custom-designed cranial implants (60%). Primary free flaps included radial forearm (n = 2) and latissimus dorsi (n = 1), with two patients later requiring anterolateral thigh flaps. Median follow-up was 10 years (range, 6.7–14.3), during which patients underwent a median of 2.5 reconstructive procedures (range, 0–6). Management of frontal bone ORN often requires complex revision cranioplasty and free flap reconstruction. Most patients required multiple surgeries to achieve stable wound healing, underscoring the importance of early recognition and consideration of prophylactic strategies in high-risk, irradiated patients. 4.
- 4 February 2026
- Published by SAGE Publications in Facial Plastic Surgery & Aesthetic Medicine
Facial Weakness in Facioscapulohumeral Muscular Dystrophy: Objective and Patient-Reported Measures to Guide Reconstructive Interventions
Introduction: Facial palsy in facioscapulohumeral muscular dystrophy (FSHD) significantly affects function and quality-of-life. Objective: To measure facial palsy burden in FSHD and assess its relationship to patient-reported outcomes and treatment-seeking behavior. Methods: In a cross-sectional study, adults with FSHD completed FACE-Q (a validated patient-reported instrument assessing perceived facial appearance, function, and quality-of-life). A subset underwent objective facial movement analysis with DynaFace analysis software. Group differences in FACE-Q scores were compared between participants with/without facial symptoms (Student’s T-test), and Pearson correlations linked objective metrics to FACE-Q domains. Results: Among 191 respondents (mean age 52 ± 16.5 years), those with facial symptoms ( n = 105) reported lower FACE-Q scores for smile, lips, appearance distress, and facial movement ( p < 0.001). Participants who sought treatment reported greater appearance-related distress ( p < 0.001), yet overall treatment use was low, with 48% receiving eye care and 1% undergoing surgery. Objective analysis demonstrated reduced eye closure and diminished smile dynamics; abnormalities in dental display and commissure excursion correlated with worse FACE-Q scores. Conclusion: Objective facial assessments revealed marked facial movement deficits in FSHD and were closely aligned with lower FACE-Q scores, implicating the functional and aesthetic burden of facial palsy in FSHD.
- 4 February 2026
- Published by SAGE Publications in Facial Plastic Surgery & Aesthetic Medicine
Facial Weakness in Facioscapulohumeral Muscular Dystrophy: Objective and Patient-Reported Measures to Guide Reconstructive Interventions
Introduction: Facial palsy in facioscapulohumeral muscular dystrophy (FSHD) significantly affects function and quality-of-life. Objective: To measure facial palsy burden in FSHD and assess its relationship to patient-reported outcomes and treatment-seeking behavior. Methods: In a cross-sectional study, adults with FSHD completed FACE-Q (a validated patient-reported instrument assessing perceived facial appearance, function, and quality-of-life). A subset underwent objective facial movement analysis with DynaFace analysis software. Group differences in FACE-Q scores were compared between participants with/without facial symptoms (Student’s T-test), and Pearson correlations linked objective metrics to FACE-Q domains. Results: Among 191 respondents (mean age 52 ± 16.5 years), those with facial symptoms ( n = 105) reported lower FACE-Q scores for smile, lips, appearance distress, and facial movement ( p < 0.001). Participants who sought treatment reported greater appearance-related distress ( p < 0.001), yet overall treatment use was low, with 48% receiving eye care and 1% undergoing surgery. Objective analysis demonstrated reduced eye closure and diminished smile dynamics; abnormalities in dental display and commissure excursion correlated with worse FACE-Q scores. Conclusion: Objective facial assessments revealed marked facial movement deficits in FSHD and were closely aligned with lower FACE-Q scores, implicating the functional and aesthetic burden of facial palsy in FSHD.
- 23 December 2025
- Published by Springer Nature
- p. 100-108
Mislabeling Misinformation: Annotation Consistency Shapes Machine Learning for DIY Health Risks
- 23 December 2025
- Published by Springer Nature
- p. 100-108
Mislabeling Misinformation: Annotation Consistency Shapes Machine Learning for DIY Health Risks
- 17 December 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 174 (2) , 386-394
The Lived Experience of Facial Paralysis: Impact of Etiology on Patient Perceptions
Objective: To evaluate how patient‐reported outcomes vary by etiology of facial paralysis and to identify functional, esthetic, and psychosocial determinants of patient lived experience. Study Design: Cross‐sectional study. Setting: Single‐center, tertiary academic facial nerve clinic. Methods: Adults with inflammatory, schwannoma, parotid neoplasm, or congenital facial paralysis completed FACE‐Q modules, the Trait Emotional Intelligence Questionnaire‐Short Form (TEIQue‐SF), and a social support rating. Facial paralysis severity was graded with Sunnybrook scores. Kruskal‐Wallis and Dunn's post hoc testing along with multivariable linear regression assessed associations between etiology and outcomes, adjusting for severity, duration, prior surgical procedures, emotional intelligence, and social support. Results: Etiology independently shaped patient experience in multiple domains. Compared with inflammatory paralysis, parotid neoplasm was associated with worse lip appearance ( β = −12.07, SE = 5.05, P = .036), speech function ( β = −16.16, SE = 6.40, P = .010), and speech‐related distress ( β = −5.51, SE = 2.11, P = .009). Congenital paralysis was linked to lower appearance distress ( β = 12.81, SE = 5.30, P = .017) and higher social functioning ( β = 17.48, SE = 7.13, P = .028). Schwannoma resection had improved facial appearance ( β = 7.96, SE = 3.03, P = .020) and psychological function ( β = 6.83, SE = 2.89, P = .037). Across etiologies, higher baseline emotional intelligence improved appearance, psychosocial, and functional perceptions, while stronger social support mitigated speech‐related distress and outcomes. Conclusion: Patient‐reported outcomes and lived experience in facial paralysis differ meaningfully by etiology. Beyond clinical severity, a patient's emotional intelligence, social context, and underlying cause of paralysis shape personal perceptions of appearance, function, and well‐being. These findings highlight the importance of etiology‐specific counseling, rehabilitation, and psychosocial support to optimize recovery and quality of life.
- 17 December 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 174 (2) , 386-394
The Lived Experience of Facial Paralysis: Impact of Etiology on Patient Perceptions
Objective: To evaluate how patient‐reported outcomes vary by etiology of facial paralysis and to identify functional, esthetic, and psychosocial determinants of patient lived experience. Study Design: Cross‐sectional study. Setting: Single‐center, tertiary academic facial nerve clinic. Methods: Adults with inflammatory, schwannoma, parotid neoplasm, or congenital facial paralysis completed FACE‐Q modules, the Trait Emotional Intelligence Questionnaire‐Short Form (TEIQue‐SF), and a social support rating. Facial paralysis severity was graded with Sunnybrook scores. Kruskal‐Wallis and Dunn's post hoc testing along with multivariable linear regression assessed associations between etiology and outcomes, adjusting for severity, duration, prior surgical procedures, emotional intelligence, and social support. Results: Etiology independently shaped patient experience in multiple domains. Compared with inflammatory paralysis, parotid neoplasm was associated with worse lip appearance ( β = −12.07, SE = 5.05, P = .036), speech function ( β = −16.16, SE = 6.40, P = .010), and speech‐related distress ( β = −5.51, SE = 2.11, P = .009). Congenital paralysis was linked to lower appearance distress ( β = 12.81, SE = 5.30, P = .017) and higher social functioning ( β = 17.48, SE = 7.13, P = .028). Schwannoma resection had improved facial appearance ( β = 7.96, SE = 3.03, P = .020) and psychological function ( β = 6.83, SE = 2.89, P = .037). Across etiologies, higher baseline emotional intelligence improved appearance, psychosocial, and functional perceptions, while stronger social support mitigated speech‐related distress and outcomes. Conclusion: Patient‐reported outcomes and lived experience in facial paralysis differ meaningfully by etiology. Beyond clinical severity, a patient's emotional intelligence, social context, and underlying cause of paralysis shape personal perceptions of appearance, function, and well‐being. These findings highlight the importance of etiology‐specific counseling, rehabilitation, and psychosocial support to optimize recovery and quality of life.
- 25 August 2023
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 170 (1) , 179-186
Murine Model of Airway Fibrosis has Anatomic, Physiologic, and Molecular Congruency to Human iSGS
Objective: To narrow knowledge gaps in the pathophysiology of idiopathic subglottic stenosis (iSGS) through comparison of a murine subglottic stenosis model with iSGS.Study Design: In vivo animal study.Setting: Academic institution.Methods: Murine samples/measurements were obtained from mice that underwent chemomechanical injury with a wire brush and bleomycin. Human samples/measurements were obtained from iSGS patients. Anatomic, physiologic, and epithelial molecular data were collected using histology, human peak expiratory flow (PEF) and murine airway conductance, gene expression analysis with quantitative polymerase chain reaction, and protein analysis with quantitative immunohistochemistry.Results: Anatomic patterns of scars at the subglottis and proximal trachea seen in the murine model are similar to iSGS patients. Subglottic stenosis (SGS) mice had a decrease (P = .0194) in airway conductance compared to healthy controls, similar to a decrease (P = .0001) in predilation PEF versus postdilation in iSGS patients. There was decreased epithelial gene expression of E‐cadherin (ECAD) (P < 0.01), occludin (OCLN) (P < .01), and cytokeratin‐5 (CK5) (P < .05) and protein expression of ECAD (H/M: P < .001), OCLN (H: P < 0.05, M: P < .001), and CK5 (H: P < .001, M: P < .01) in murine SGS and iSGS versus controls.Conclusion: The murine SGS model shows anatomic, physiologic, and molecular congruency with human iSGS, making it a reasonable model to investigate iSGS. The molecular similarities in epithelial barrier dysfunction suggest it may best be suited to explore epithelial mechanisms of iSGS and therapies directed at epithelial reconstitution. This model provides a foundation to collect data that will improve understanding of iSGS, and, ultimately, translate into more accurate animal models for future use.
- 25 August 2023
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 170 (1) , 179-186
Murine Model of Airway Fibrosis has Anatomic, Physiologic, and Molecular Congruency to Human iSGS
Objective: To narrow knowledge gaps in the pathophysiology of idiopathic subglottic stenosis (iSGS) through comparison of a murine subglottic stenosis model with iSGS.Study Design: In vivo animal study.Setting: Academic institution.Methods: Murine samples/measurements were obtained from mice that underwent chemomechanical injury with a wire brush and bleomycin. Human samples/measurements were obtained from iSGS patients. Anatomic, physiologic, and epithelial molecular data were collected using histology, human peak expiratory flow (PEF) and murine airway conductance, gene expression analysis with quantitative polymerase chain reaction, and protein analysis with quantitative immunohistochemistry.Results: Anatomic patterns of scars at the subglottis and proximal trachea seen in the murine model are similar to iSGS patients. Subglottic stenosis (SGS) mice had a decrease (P = .0194) in airway conductance compared to healthy controls, similar to a decrease (P = .0001) in predilation PEF versus postdilation in iSGS patients. There was decreased epithelial gene expression of E‐cadherin (ECAD) (P < 0.01), occludin (OCLN) (P < .01), and cytokeratin‐5 (CK5) (P < .05) and protein expression of ECAD (H/M: P < .001), OCLN (H: P < 0.05, M: P < .001), and CK5 (H: P < .001, M: P < .01) in murine SGS and iSGS versus controls.Conclusion: The murine SGS model shows anatomic, physiologic, and molecular congruency with human iSGS, making it a reasonable model to investigate iSGS. The molecular similarities in epithelial barrier dysfunction suggest it may best be suited to explore epithelial mechanisms of iSGS and therapies directed at epithelial reconstitution. This model provides a foundation to collect data that will improve understanding of iSGS, and, ultimately, translate into more accurate animal models for future use.
- 10 August 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (1) , 374-381
Dysfunctional Epithelial Barrier Is Characterized by Reduced E‐Cadherin in Idiopathic Subglottic Stenosis
Objectives: To aim of the study was to characterize the molecular profile and functional phenotype of idiopathic subglottic stenosis (iSGS)‐scar epithelium.Methods: Human tracheal biopsies from iSGS scar (n = 6) and matched non‐scar (n = 6) regions were analyzed using single‐cell RNA sequencing (scRNA‐seq). Separate specimens were used for epithelial cell expansion in vitro to assess average growth rate and functional capabilities using transepithelial‐electrical resistance (TEER), fluorescein isothiocyanate‐dextran flux permeability assay, ciliary coverage, and cilia beating frequency (CBF). Finally, epithelial tight junction protein expression of cultured cells was quantified using immunoblot assay (n = 4) and immunofluorescence (n = 6).Results: scRNA‐seq analysis revealed a decrease in goblet, ciliated, and basal epithelial cells in the scar iSGS cohort. Furthermore, mRNA expression of proteins E‐cadherin, claudin‐3, claudin‐10, occludin, TJP1, and TJP2 was also reduced (p < 0.001) in scar epithelium. Functional assays demonstrated a decrease in TEER (paired 95% confidence interval [CI], 195.68–890.83 Ω × cm2, p < 0.05), an increase in permeability (paired 95% CI, −6116.00 to −1401.99 RFU, p < 0.05), and reduced epithelial coverage (paired 95% CI, 0.1814–1.766, fold change p < 0.05) in iSGS‐scar epithelium relative to normal controls. No difference in growth rate (p < 0.05) or CBF was found (paired 95% CI, −2.118 to 3.820 Hz, p > 0.05). Immunoblot assay (paired 95% CI, 0.0367–0.605, p < 0.05) and immunofluorescence (paired 95% CI, 13.748–59.191 mean grey value, p < 0.05) revealed E‐cadherin reduction in iSGS‐scar epithelium.Conclusion: iSGS‐scar epithelium has a dysfunctional barrier and reduced structural protein expression. These results are consistent with dysfunctional epithelium seen in other airway pathology. Further studies are warranted to delineate the causality of epithelial dysfunction on the downstream fibroinflammatory cascade in iSGS.Level of Evidence: NA Laryngoscope, 134:374–381, 2024
- 10 August 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (1) , 374-381
Dysfunctional Epithelial Barrier Is Characterized by Reduced E‐Cadherin in Idiopathic Subglottic Stenosis
Objectives: To aim of the study was to characterize the molecular profile and functional phenotype of idiopathic subglottic stenosis (iSGS)‐scar epithelium.Methods: Human tracheal biopsies from iSGS scar (n = 6) and matched non‐scar (n = 6) regions were analyzed using single‐cell RNA sequencing (scRNA‐seq). Separate specimens were used for epithelial cell expansion in vitro to assess average growth rate and functional capabilities using transepithelial‐electrical resistance (TEER), fluorescein isothiocyanate‐dextran flux permeability assay, ciliary coverage, and cilia beating frequency (CBF). Finally, epithelial tight junction protein expression of cultured cells was quantified using immunoblot assay (n = 4) and immunofluorescence (n = 6).Results: scRNA‐seq analysis revealed a decrease in goblet, ciliated, and basal epithelial cells in the scar iSGS cohort. Furthermore, mRNA expression of proteins E‐cadherin, claudin‐3, claudin‐10, occludin, TJP1, and TJP2 was also reduced (p < 0.001) in scar epithelium. Functional assays demonstrated a decrease in TEER (paired 95% confidence interval [CI], 195.68–890.83 Ω × cm2, p < 0.05), an increase in permeability (paired 95% CI, −6116.00 to −1401.99 RFU, p < 0.05), and reduced epithelial coverage (paired 95% CI, 0.1814–1.766, fold change p < 0.05) in iSGS‐scar epithelium relative to normal controls. No difference in growth rate (p < 0.05) or CBF was found (paired 95% CI, −2.118 to 3.820 Hz, p > 0.05). Immunoblot assay (paired 95% CI, 0.0367–0.605, p < 0.05) and immunofluorescence (paired 95% CI, 13.748–59.191 mean grey value, p < 0.05) revealed E‐cadherin reduction in iSGS‐scar epithelium.Conclusion: iSGS‐scar epithelium has a dysfunctional barrier and reduced structural protein expression. These results are consistent with dysfunctional epithelium seen in other airway pathology. Further studies are warranted to delineate the causality of epithelial dysfunction on the downstream fibroinflammatory cascade in iSGS.Level of Evidence: NA Laryngoscope, 134:374–381, 2024
- Open Access
- 12 January 2023
- Published by Wiley in The Laryngoscope
- Vol. 133 (9) , 2346-2356
Myeloid Phenotypes in Tracheostomy‐Associated Granulation Tissue
Objective(s): Tracheostomy‐associated granulation tissue is a common, recurrent problem occurring secondary to chronic mucosal irritation. Although granulation tissue is composed of predominantly innate immune cells, the phenotype of monocytes and macrophages in tracheostomy‐associated granulation tissue is unknown. This study aims to define the myeloid cell population in granulation tissue secondary to tracheostomy.Methods: Granulation tissue biopsies were obtained from 8 patients with tracheostomy secondary to laryngotracheal stenosis. Cell type analysis was performed by flow cytometry and gene expression was measured by quantitative real‐time polymerase chain reaction. These methods and immunohistochemistry were used to define the monocyte/macrophage population in granulation tissue and were compared to tracheal autopsy control specimens.Results: Flow cytometry demonstrated macrophages (CD45+CD11b+) and monocytes (CD45+FSClowSSClow) represent 23.2 ± 6% of the granulation tissue cell population. The M2 phenotype (CD206) is present in 77 ± 11% of the macrophage population and increased compared to the M1 phenotype (p = 0.012). Classical monocytes (CD45+CD14highCD16low) were increased in granulation tissue compared to controls (61.2 ± 7% and 30 ± 8.5%, p = 0.038). Eighty‐five percent of macrophages expressed pro‐inflammatory S100A8/A9 and 36 ± 4% of macrophages co‐localized CD169, associated with tissue‐resident macrophages. M2 gene expression (Arg1/CD206) was increased in granulation tissue (3.7 ± 0.4, p = 0.035 and 3.5 ± 0.5, p = 0.047) whereas M1 gene expression (CD80/CD86) was similar to controls (p = 0.64, p = 0.3). Immunohistochemistry of granulation tissue demonstrated increased cells co‐localizing CD11b and CD206.Conclusions: M2 macrophages are the dominant macrophage phenotype in tracheostomy‐associated granulation tissue. The role of this cell type in promoting ongoing inflammation warrants future investigation to identify potential treatments for granulation tissue secondary to tracheostomy.Level of Evidence: 3 Laryngoscope, 133:2346–2356, 2023
- 12 January 2023
- Published by Wiley in The Laryngoscope
- Vol. 133 (9) , 2346-2356
Open AccessMyeloid Phenotypes in Tracheostomy‐Associated Granulation Tissue
Objective(s): Tracheostomy‐associated granulation tissue is a common, recurrent problem occurring secondary to chronic mucosal irritation. Although granulation tissue is composed of predominantly innate immune cells, the phenotype of monocytes and macrophages in tracheostomy‐associated granulation tissue is unknown. This study aims to define the myeloid cell population in granulation tissue secondary to tracheostomy.Methods: Granulation tissue biopsies were obtained from 8 patients with tracheostomy secondary to laryngotracheal stenosis. Cell type analysis was performed by flow cytometry and gene expression was measured by quantitative real‐time polymerase chain reaction. These methods and immunohistochemistry were used to define the monocyte/macrophage population in granulation tissue and were compared to tracheal autopsy control specimens.Results: Flow cytometry demonstrated macrophages (CD45+CD11b+) and monocytes (CD45+FSClowSSClow) represent 23.2 ± 6% of the granulation tissue cell population. The M2 phenotype (CD206) is present in 77 ± 11% of the macrophage population and increased compared to the M1 phenotype (p = 0.012). Classical monocytes (CD45+CD14highCD16low) were increased in granulation tissue compared to controls (61.2 ± 7% and 30 ± 8.5%, p = 0.038). Eighty‐five percent of macrophages expressed pro‐inflammatory S100A8/A9 and 36 ± 4% of macrophages co‐localized CD169, associated with tissue‐resident macrophages. M2 gene expression (Arg1/CD206) was increased in granulation tissue (3.7 ± 0.4, p = 0.035 and 3.5 ± 0.5, p = 0.047) whereas M1 gene expression (CD80/CD86) was similar to controls (p = 0.64, p = 0.3). Immunohistochemistry of granulation tissue demonstrated increased cells co‐localizing CD11b and CD206.Conclusions: M2 macrophages are the dominant macrophage phenotype in tracheostomy‐associated granulation tissue. The role of this cell type in promoting ongoing inflammation warrants future investigation to identify potential treatments for granulation tissue secondary to tracheostomy.Level of Evidence: 3 Laryngoscope, 133:2346–2356, 2023
- 16 December 2022
- Published by Wiley in The Laryngoscope
- Vol. 133 (9) , 2308-2316
Characterizing the Macrophage Population in Patients With Idiopathic Subglottic Stenosis
Objectives: Idiopathic subglottic stenosis (iSGS) is characterized by progressive fibrosis and subglottic luminal narrowing. Currently, immune characterization has focused on T‐cells; however, macrophages remain largely unexplored. The goals of this study are to characterize the transcriptome of iSGS macrophages and the fibrogenic nature of identifed biomarkers.Study Design: Bioinformatics and in vitro.Methods: Human tracheal biopsies from iSGS scar (n = 4), and matched non‐scar (n = 4) regions were analyzed using single‐cell RNA‐seq (scRNA‐seq). Immunofluorescence (IF) was performed on rapidly processed autopsies (RPA) and iSGS tracheal resections (n = 4) to co‐localize S100A8/9 and CD11b. Collagen gene/protein expression was assessed in iSGS fibroblasts (n = 4) treated with protein S100A8/9 (1000 ng/ml). Macrophages were subclustered to identify distinct subpopulations.Results: scRNA‐seq analysis revealed S100A8/S100A9 (fold change (FC) = 4.1/1.88, p < 0.001) as top differentially expressed genes in iSGS macrophages. IF exhibited increased CD11b+/S100A8/9+ cells in tracheal samples of iSGS versus RPA (26.75% ± 7.08 vs. 0.594% ± 0.974, n = 4, p = 0.029). iSGS fibroblasts treated with S100A8/9 demonstrated increased gene expression of COL1A1 (FC = 2.30 ± 0.45, p = 0.03, n = 4) and COL3A1 (FC = 2.44 ± 0.40, p = 0.03, n = 4). COL1A1 protein assays revealed an increase in the experimental group, albeit not significant, (p = 0.12, n = 4). Finally, macrophage sub clustering revealed one subpopulation as a predominant source of S100A8/S100A9 expression (FC = 7.94/5.47, p < 0.001).Conclusions: S100A8/9 is a key biomarker in iSGS macrophages. Although S100A8/9 demonstrates profibrotic nature in vitro, the role of S100A8/9+ macrophages in vivo warrants further investigation.Level of Evidence: NA Laryngoscope, 133:2308–2316, 2023
- 16 December 2022
- Published by Wiley in The Laryngoscope
- Vol. 133 (9) , 2308-2316
Characterizing the Macrophage Population in Patients With Idiopathic Subglottic Stenosis
Objectives: Idiopathic subglottic stenosis (iSGS) is characterized by progressive fibrosis and subglottic luminal narrowing. Currently, immune characterization has focused on T‐cells; however, macrophages remain largely unexplored. The goals of this study are to characterize the transcriptome of iSGS macrophages and the fibrogenic nature of identifed biomarkers.Study Design: Bioinformatics and in vitro.Methods: Human tracheal biopsies from iSGS scar (n = 4), and matched non‐scar (n = 4) regions were analyzed using single‐cell RNA‐seq (scRNA‐seq). Immunofluorescence (IF) was performed on rapidly processed autopsies (RPA) and iSGS tracheal resections (n = 4) to co‐localize S100A8/9 and CD11b. Collagen gene/protein expression was assessed in iSGS fibroblasts (n = 4) treated with protein S100A8/9 (1000 ng/ml). Macrophages were subclustered to identify distinct subpopulations.Results: scRNA‐seq analysis revealed S100A8/S100A9 (fold change (FC) = 4.1/1.88, p < 0.001) as top differentially expressed genes in iSGS macrophages. IF exhibited increased CD11b+/S100A8/9+ cells in tracheal samples of iSGS versus RPA (26.75% ± 7.08 vs. 0.594% ± 0.974, n = 4, p = 0.029). iSGS fibroblasts treated with S100A8/9 demonstrated increased gene expression of COL1A1 (FC = 2.30 ± 0.45, p = 0.03, n = 4) and COL3A1 (FC = 2.44 ± 0.40, p = 0.03, n = 4). COL1A1 protein assays revealed an increase in the experimental group, albeit not significant, (p = 0.12, n = 4). Finally, macrophage sub clustering revealed one subpopulation as a predominant source of S100A8/S100A9 expression (FC = 7.94/5.47, p < 0.001).Conclusions: S100A8/9 is a key biomarker in iSGS macrophages. Although S100A8/9 demonstrates profibrotic nature in vitro, the role of S100A8/9+ macrophages in vivo warrants further investigation.Level of Evidence: NA Laryngoscope, 133:2308–2316, 2023
- 1 April 2022
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 29 (4) , 507-518
Virtual Reality Simulation Has Weak Correlation with Overall Trainee Robot-Assisted Laparoscopic Hysterectomy Performance
- 1 April 2022
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 29 (4) , 507-518
Virtual Reality Simulation Has Weak Correlation with Overall Trainee Robot-Assisted Laparoscopic Hysterectomy Performance
- Open Access
- 31 March 2022
- Published by Wiley in The Laryngoscope
- Vol. 133 (3) , 500-505
Eye Tracking and Motion Data Predict Endoscopic Sinus Surgery Skill
Objective: Endoscopic surgery has a considerable learning curve due to dissociation of the visual‐motor axes, coupled with decreased tactile feedback and mobility. In particular, endoscopic sinus surgery (ESS) lacks objective skill assessment metrics to provide specific feedback to trainees. This study aims to identify summary metrics from eye tracking, endoscope motion, and tool motion to objectively assess surgeons' ESS skill.Methods: In this cross‐sectional study, expert and novice surgeons performed ESS tasks of inserting an endoscope and tool into a cadaveric nose, touching an anatomical landmark, and withdrawing the endoscope and tool out of the nose. Tool and endoscope motion were collected using an electromagnetic tracker, and eye gaze was tracked using an infrared camera. Three expert surgeons provided binary assessments of low/high skill. 20 summary statistics were calculated for eye, tool, and endoscope motion and used in logistic regression models to predict surgical skill.Results: 14 metrics (10 eye gaze, 2 tool motion, and 2 endoscope motion) were significantly different between surgeons with low and high skill. Models to predict skill for 6/9 ESS tasks had an AUC >0.95. A combined model of all tasks (AUC 0.95, PPV 0.93, NPV 0.89) included metrics from eye tracking data and endoscope motion, indicating that these metrics are transferable across tasks.Conclusions: Eye gaze, endoscope, and tool motion data can provide an objective and accurate measurement of ESS surgical performance. Incorporation of these algorithmic techniques intraoperatively could allow for automated skill assessment for trainees learning endoscopic surgery.Level of Evidence: N/A Laryngoscope, 133:500–505, 2023
- 31 March 2022
- Published by Wiley in The Laryngoscope
- Vol. 133 (3) , 500-505
Open AccessEye Tracking and Motion Data Predict Endoscopic Sinus Surgery Skill
Objective: Endoscopic surgery has a considerable learning curve due to dissociation of the visual‐motor axes, coupled with decreased tactile feedback and mobility. In particular, endoscopic sinus surgery (ESS) lacks objective skill assessment metrics to provide specific feedback to trainees. This study aims to identify summary metrics from eye tracking, endoscope motion, and tool motion to objectively assess surgeons' ESS skill.Methods: In this cross‐sectional study, expert and novice surgeons performed ESS tasks of inserting an endoscope and tool into a cadaveric nose, touching an anatomical landmark, and withdrawing the endoscope and tool out of the nose. Tool and endoscope motion were collected using an electromagnetic tracker, and eye gaze was tracked using an infrared camera. Three expert surgeons provided binary assessments of low/high skill. 20 summary statistics were calculated for eye, tool, and endoscope motion and used in logistic regression models to predict surgical skill.Results: 14 metrics (10 eye gaze, 2 tool motion, and 2 endoscope motion) were significantly different between surgeons with low and high skill. Models to predict skill for 6/9 ESS tasks had an AUC >0.95. A combined model of all tasks (AUC 0.95, PPV 0.93, NPV 0.89) included metrics from eye tracking data and endoscope motion, indicating that these metrics are transferable across tasks.Conclusions: Eye gaze, endoscope, and tool motion data can provide an objective and accurate measurement of ESS surgical performance. Incorporation of these algorithmic techniques intraoperatively could allow for automated skill assessment for trainees learning endoscopic surgery.Level of Evidence: N/A Laryngoscope, 133:500–505, 2023